MAPT and Alzheimer disease: The lower levels of Drp1 under conditions of Nrf2 activation could be beneficial in AD as partial reduction of Drp1 decreases the levels of phosphorylated Tau, a major microtubule‐associated protein (MAPT) of mature neurons, and improves mitochondrial dynamics and synaptic activity in Tau transgenic (P301L) mice 46.